SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Cocrystal Pharma entered into a securities purchase agreement with OPKO Health, Inc. for the sale of common stock. The terms set a floor for the share price based on the Nasdaq Con…
Sally Beauty Holdings Q3 fiscal 2026 net sales rose 0.2% as GAAP diluted EPS increased 25%. The company repurchased $25 million in shares and narrowed full year guidance.
BCB Bancorp reported a second-quarter net loss of $14.8 million due to a $19.0 million credit loss provision, dropping its efficiency ratio to 96.8%. The company also announced its…
The company plans to submit its AXPAXLI NDA for wet AMD in Q4 2026 and reported a balance of $598.6M to support commercialization efforts.
SmartKem plans a reverse merger with Ferrox, following board approval, to combine operations under SMTK.
TG Therapeutics reported Q2 2026 total global revenue of approximately $240 million, exceeding its guidance. The company raised its full year financial targets as BRIUMVI commercia…
Tonix Pharmaceuticals announced positive feedback for the design of an adaptive Phase 2 Lyme disease study of TNX-4800, with plans to begin the trial in early 2027. The long-acting…
Krystal Bio reported $119.2M in VYJUVEK revenue for Q2 2026, showcasing growing commercial traction. Maintaining a $1.1B cash balance, the company is on track for launches in Spain…
The company announced full enrollment in its BUOY-1 Phase 2b trial of GlyphAllo for MDD and shared financial highlights, advancing its pipeline of neuropsychiatric therapies.
D-Wave Quantum announced a collaboration with Nasdaq Verafin to evaluate quantum-hybrid technology for improving predictive systems in financial crime detection, potentially enhanc…
Autolus issued a warrant certificate for up to 3.5 million ADSs to Perceptive Credit Holdings, as a loan condition. The securities are unregistered.
Bioxcel Therapeutics, Inc. and its lenders amended the Existing Credit Agreement dated April 19, 2022, subject to the satisfaction of certain conditions precedent, as set forth in …
CPHC announced the acquisition of The Advocacy Partners for an immediately earnings accretive price. The deal creates a national footprint in state-level government relations and l…
Marriott International, Inc. reported strong Q2 2026 results with global RevPAR increasing 3.4% year-over-year due to solid demand in the U.S. & Canada, while the company raised it…
Institutional holdings report (13F-HR) filed by Rising Stella Capital Pte. Ltd.
Southern Company announced a private placement of $650M and $1.5B in convertible senior notes, targeting qualified institutional buyers. This financing activity impacts the company…
Indivior posted record quarterly net revenues and raised 2026 full-year guidance driven by strong SUBLOCADE performance. The company also announced a merger agreement with Supernus…
Supernus Pharmaceuticals reported a strong revenue increase, raising its full-year guidance and agreeing to merge with Indivior to enhance its CNS portfolio.
The REIT reported net income of $3.2 million in Q2 2026 and plans to raise 2026 guidance. It also closed a new $200 million senior unsecured term loan facility with an accordion op…
Supernus Pharmaceuticals and Indivior Pharmaceuticals have entered into a definitive merger agreement under which Supernus will acquire Indivior. The agreement was reached to combi…